Xponance, Inc. Emergent Bio Solutions Inc. Transaction History

Xponance, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$33.11 - $55.01 $242,133 - $402,288	-7,313 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$50.07 - $66.05 $6,709 - $8,850	-134 Reduced 1.8%	7,313 $366,000
Q2 2021 Aug 12, 2021	BUY	$56.61 - $80.46 $135,750 - $192,943	2,398 Added 47.49%	7,447 $469,000
Q1 2021 May 10, 2021	SELL	$86.23 - $125.19 $86,747 - $125,941	-1,006 Reduced 16.61%	5,049 $469,000
Q4 2020 Feb 11, 2021	BUY	$79.17 - $111.47 $712 - $1,003	9 Added 0.15%	6,055 $543,000
Q3 2020 Oct 26, 2020	BUY	$81.91 - $134.94 $495,227 - $815,847	6,046 New	6,046 $625,000

162

33.2M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $522M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.